Purchase Order 75D30124P19969
- Not listed
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of the Air Force Materiel Command to Meridian Bioscience Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The $154,150.00 contract is for the delivery of in vitro diagnostic substances, reagents, test kits, and sets, with a period of performance ending on September 30, 2018. There was no set-aside designation used for this award. Meridian Bioscience...
- This is a definitive contract awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The contract, valued at $274,884.11, is for the supply of "PREMIER PLATINUM HPSA PLUS KITS" with a completion date of September 30, 2021. The contract is a firm fixed-price arrangement. Meridian Bioscience Inc. is a key supplier of diagnostic solutions to...
- This federal contract award, with an ID of FA860114A0001|0002, was issued by the Air Force Materiel Command (AFMC) to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The contract, valued at $94,120.00, is a Blanket Purchase Agreement (BPA) call for the "601396 PREMIER PLATINUM HPSA PLUS" requirement. It is a firm-fixed-price contract with a completion date of May 29, 2016. The contract does not have a...
- This federal contract award was made by the Northeast Area of the U.S. Department of Agriculture to Bioline USA Inc., a subsidiary of Meridian Bioscience Inc., for the purchase of a 2-channel MIC Magnetic Induction Cycler. The award was a firm-fixed price purchase order with a ceiling value of $10,625. There was no set-aside designation used for this contract. Meridian Bioscience Inc. is a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and diagnostic instruments. The contract, valued at $72,684.00, is for the delivery of FY24 base option year Curian HPSA assay products (contract number W81K0023P0057). The contract has a period of performance through September 30, 2026 and was awarded on October 1, 2023. There is no...
- This is a firm-fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The contract, valued at $99,400.00, is for the provision of Group B Streptococcus (GBS) kits and Clostridioides difficile (C. diff) test kits. The contract does not have a set-aside designation and has an ultimate completion date of May 31, 2017. Meridian Bioscience...
- The Indian Health Service awarded a Blanket Purchase Agreement (BPA) call valued at $181.4K to Meridian Bioscience Inc. for laboratory supplies and extended warranty services under the Year-2 BPA Call 24A00011-25F28002. This firm fixed-price contract, which includes a correction to unit pricing for identification kits, will be performed in Phoenix, Arizona, with an ultimate completion date of June 16, 2026. The award was made without a set-aside designation, reflecting Meridian Bioscience's...
- The federal contract award was made to Biomerieux Inc., a global leader in in vitro diagnostics, through its Biomerieux, Inc. Division. The $12,709.58 firm-fixed-price purchase order is for the procurement of reagents and was placed by the Centers for Disease Control and Prevention (CDC) Pittsburgh field office, a civilian agency. The contract does not have a set-aside designation, as Biomerieux is the sole source provider for its proprietary diagnostic platforms, such as VITEK, BioFire, and...
- The U.S. government awarded a $14,821 firm fixed-price purchase order to Bioline USA Inc., a small business subsidiary of Meridian Bioscience Inc., for a MIC (Magnetic Induction Cycler) 4-channel system with HRM (High Resolution Melting) capabilities, including tubes and caps. The contract was set aside for total small business and awarded on September 26, 2016, with a completion date of October 25, 2016. Performance of the work is to take place in Taunton, Massachusetts. The funding agency is...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Meridian Bioscience Inc., a manufacturer of in vitro diagnostic test kits, reagents, and instruments for the Tripler Army Medical Center in Hawaii. The contract, which has no set-aside designation, is for the delivery of Meridian reagents required for various clinical testing and screening applications at the medical center, including for varicella zoster virus, mycoplasma, rotavirus, mononucleosis, ova and...
This federal contract award to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments, is for the provision of laboratory reagents for the Centers for Disease Control and Prevention (CDC) Pittsburgh facility. The contract, valued at $49,466.00, is a firm fixed-price purchase order with an ultimate completion date of November 1, 2024. The contract does not have a set-aside designation. Meridian Bioscience is a key supplier of diagnostic solutions to various U.S. federal agencies, including the Department of Defense, Department of Veterans Affairs, Department of State, and Department of Health and Human Services. The company has been awarded multiple Blanket Purchase Agreements (BPAs) with federal agencies, including the Department of Veterans Affairs and the Indian Health Service, demonstrating its capability to provide comprehensive diagnostic solutions to federal healthcare facilities over extended periods.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.5k | 8/28/24 |